Search results for "THERAPY"

showing 10 items of 12482 documents

2014

Background and purpose: A substantial reduction of uncertainties in clinical brachytherapy should result in improved outcome in terms of increased local control and reduced side effects. Types of uncertainties have to be identified, grouped, and quantified. Methods: A detailed literature review was performed to identify uncertainty components and their relative importance to the combined overall uncertainty. Results: Very few components (e.g., source strength and afterloader timer) are independent of clinical disease site and location of administered dose. While the influence of medium on dose calculation can be substantial for low energy sources or non-deeply seated implants, the influence…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentBrachytherapyDose fractionationHematologySchedule (project management)Clinical disease030218 nuclear medicine & medical imaging3. Good health03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisAbsorbed doseTotal dosemedicineDosimetryRadiology Nuclear Medicine and imagingMedical physicsRadiation treatment planningbusinessRadiotherapy and Oncology
researchProduct

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances

2020

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCEFTOLOZANE/TAZOBACTAMMEDLINElcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Critical Care and Intensive Care MedicineTazobactammedicineRenal replacement therapyIntensive care medicinebusinessmedicine.drugCritical Care
researchProduct

EP-1612: Intraluminal radiotherapy in the treatment of inoperable cancer of the esophagus

2015

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCancerHematologymedicine.diseaseRadiation therapymedicine.anatomical_structureOncologyRadiology Nuclear Medicine and imagingmedicineRadiology Nuclear Medicine and imagingRadiologyEsophagusbusinessRadiotherapy and Oncology
researchProduct

Role of CRT upgrading in pacing induced heart failure: A case report

2014

Abstract We submit a case report of a 78-year-old male came to our department for systolic heart, failure (EF of 25%). He has clinical history of recurring atrial tachycardia and atrial flutter previously treated in our department unsuccessfully with antiarrhythmic drug therapy. The echocardiographic evidence of left atrial enlargement (left atrium area 40 cm 2 ) and the clinical history of permanent atrial tachycardia has discouraged any attempt of substrate ablation. As it is impossible get rhythm and rate control with drug therapy, the patient was subjected to an "ablate and pace" procedure with implantation of a VVIR mode pacemaker. Also, for the absence of indications (QRS width During…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCardiac resynchronization therapyFurosemidemedicine.diseaseHeart failureInternal medicineACE inhibitorcardiovascular systemmedicineLeft atrial enlargementCardiologycardiovascular diseasesmedicine.symptombusinessAdverse effectAtrial tachycardiaAtrial fluttermedicine.drugJournal of Indian College of Cardiology
researchProduct

Chronisch thromboembolische pulmonale Hypertonie: Empfehlungen der Kölner Konsensus Konferenz 2016

2016

The 2015 European Guidelines on Pulmonary Hypertension did not cover only pulmonary arterial hypertension (PAH), but also other significant subgroups of pulmonary hypertension (PH). In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany to discuss open and controversial issues surrounding the practical implementation of the European Guidelines. Several working groups were initiated, one of which was dedicated to the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). In ev…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentConsensus conference610 Medicine & health2700 General MedicineGeneral Medicine030204 cardiovascular system & hematologymedicine.diseasePulmonary hypertension3. Good healthPulmonary endarterectomy03 medical and health sciences0302 clinical medicinePharmacotherapy030228 respiratory systemAngioplastymedicine.arteryPulmonary arterymedicineChronic thromboembolic pulmonary hypertension10178 Clinic for PneumologyIntensive care medicinebusinessPediatric cardiologyDMW - Deutsche Medizinische Wochenschrift
researchProduct

Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma

2011

Objective  The aim of this study was to evaluate the safety and efficacy profile of pegylated interferon α-2b (PEG-IFN α-2b) in combination with photochemotherapy (PUVA) in the treatment of cutaneous T-cell lymphoma (CTCL) in comparison with standard IFN α plus PUVA. Design  Retrospective cohort study over a period of 7 years. Patients and interventions  A total of 17 consecutive CTCL patients (stage IA–IV) were retrospectively analysed for toxicity and response rates associated with PEG-IFN α-2b (1.5 μg/kg weekly) plus PUVA (n = 9) or standard IFN α-2a (9 MIU 3×/week) plus PUVA (n = 8). Main outcome measures  Differences of response rates (complete/partial remission), progression-free surv…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCutaneous T-cell lymphomaDermatologymedicine.diseaseDermatologyGastroenterologyDiscontinuationchemistry.chemical_compoundInfectious DiseaseschemistryPegylated interferonInternal medicinePUVA therapyToxicitymedicinebusinessProspective cohort studyAdverse effectPsoralenmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct

Chimioradiothérapie des cancers de l’œsophage : quelles aires ganglionnaires faut-il irradier ?

2014

Esophageal cancer has a high likelihood of distant lymphatic spread even at an early stage. Radiotherapy plays a major role in the management of localized or locally-advanced esophageal cancer with a regional or distant lymph node involvement. Radiotherapy can sterilize micrometastatic nodes and cancer cells in transit in the peri-esophageal fat that are not removed by surgery. After preoperative chemoradiotherapy followed by monobloc esophagectomy including lymph node dissection above and below the diaphragm, the locoregional failure rate was around 3% in the Chemoradiotherapy for Esophageal Cancer followed by Surgery Study Group (CROSS) trial. This is significantly lower than that observe…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentEsophageal cancermedicine.diseaseRadiation therapyDissectionmedicine.anatomical_structureOncologyEsophagectomymedicineDistant Lymph NodeRadiology Nuclear Medicine and imagingRadiologyStage (cooking)businessLymph nodeChemoradiotherapyCancer/Radiothérapie
researchProduct

Variceal ulceration following sclerotherapy: normal consequence or complication?

1990

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentGastroenterologyEsophageal DiseasesEsophageal and Gastric VaricesSurgeryNecrosisSclerotherapySclerotherapyHumansMedicineRadiology Nuclear Medicine and imagingEsophagoscopybusinessComplicationUlcerGastrointestinal Endoscopy
researchProduct

Radiotherapy for Graves’ ophthalmopathy

2000

The interest in the treatment of benign diseases with radiation therapy has grown particularly in the Western part of the world. In 1996, a questionnaire was sent to 1348 institutes worldwide listed in the directory of the Society for Therapeutic Radiology and Oncology asking whether the respondents considered a list of 28 most common benign disorders as being a good indication for orbital radiotherapy.1 Questions concerned the frequency of such treatments and the treatment schedules used. The prevention of keloid formation was the most widely accepted indication, followed by Graves’ ophthalmopathy. Thus, radiotherapy for this orbital disorder is generally accepted and applied worldwide.

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentGeneral surgeryOrbital radiotherapySoft tissue changemedicine.diseaseTherapeutic RadiologyRadiation therapyGraves' ophthalmopathyEndocrinologyKeloid formationInternal medicinemedicinebusiness
researchProduct

Applying Modern Pain Neuroscience in Clinical Practice: Criteria for the Classification of Central Sensitization Pain

2014

Background: The awareness is growing that central sensitization is of prime importance for the assessment and management of chronic pain, but its classification is challenging clinically since no gold standard method of assessment exists. Objectives: Designing the first set of classification criteria for the classification of central sensitization pain. Methods: A body of evidence from original research papers was used by 18 pain experts from 7 different countries to design the first classification criteria for central sensitization pain. Results: It is proposed that the classification of central sensitization pain entails 2 major steps: the exclusion of neuropathic pain and the differentia…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentGold standardChronic painmedicine.diseaseLow back painCognitive behavioral therapyAnesthesiology and Pain MedicinePhysical medicine and rehabilitationAllodyniaNeuropathic painHyperalgesiaPhysical therapyChronic fatigue syndromeMedicinemedicine.symptombusinessPain Physician
researchProduct